Across TCGA pan-cancer cohorts, FCF1P10 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated FCF1P10 data layer.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher FCF1P10 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated FCF1P10 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.
LUSC, THCA, and PCPG are the cancer types where FCF1P10 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.